Blog

Archive for the ‘bioengineering’ category

Aug 8, 2018

Journal Club July 2018 — CRISPR may cause unwanted mutations

Posted by in categories: bioengineering, biotech/medical, genetics

The July edition of the Journal Club has us taking a look at a recent paper that casts doubt and concern over the use of CRISPR Cas9 for gene editing.

If you like watching these streams and/or would like to participate in future streams, please consider supporting us by becoming a Lifespan Hero: https://www.lifespan.io/hero

The paper we are discussing can be found here: https://www.nature.com/articles/nbt.

Continue reading “Journal Club July 2018 — CRISPR may cause unwanted mutations” »

Aug 1, 2018

Researchers successfully transplant bioengineered lung

Posted by in categories: bioengineering, biotech/medical

A research team at the University of Texas Medical Branch have bioengineered lungs and transplanted them into adult pigs with no medical complication.

In 2014, Joan Nichols and Joaquin Cortiella from The University of Texas Medical Branch at Galveston were the first research team to successfully bioengineer human lungs in a lab. In a paper now available in Science Translational Medicine, they provide details of how their work has progressed from 2014 to the point no complications have occurred in the pigs as part of standard preclinical testing.

“The number of people who have developed severe lung injuries has increased worldwide, while the number of available transplantable organs have decreased,” said Cortiella, professor of pediatric anesthesia. “Our ultimate goal is to eventually provide new options for the many people awaiting a transplant,” said Nichols, professor of internal medicine and associate director of the Galveston National Laboratory at UTMB.

Continue reading “Researchers successfully transplant bioengineered lung” »

Aug 1, 2018

Grow-your-own organs could be here within five years, as scientists prove they work in pigs

Posted by in categories: bioengineering, biotech/medical

Grow-your-own organs could be available for desperately ill patients within five years, after scientists successfully transplanted bioengineered lungs into pigs for the first time.

The team at the University of Texas Medical Branch (UTMB) showed that lab-grown organs were quickly accepted by the animals, and within just two weeks had developed a network of blood vessels.

Previous attempts have failed with several hours of transplantation because the organs did not establish the complicated web of vessels needed for proper oxygen and blood flow.

Continue reading “Grow-your-own organs could be here within five years, as scientists prove they work in pigs” »

Jul 30, 2018

Bioquark Inc. — Future Tech Podcast — Ira Pastor

Posted by in categories: aging, bioengineering, biological, business, cryonics, futurism, genetics, health, neuroscience, transhumanism

The Disease Time Machine – Ira Pastor – CEO, Bioquark, Inc. – How the Study of Organisms May Show Us the Way to Turn Back Time for Cell Regeneration

Jul 30, 2018

A Moon For All Mankind

Posted by in categories: bioengineering, space travel, virtual reality

Few in life get to walk on the Moon. Samsung says, do what you can’t. Working with creative agency Iris and engineering experts Mannetron, Framestore proudly joined Samsung’s mission to bring space travel to all, in the approach to the 50th anniversary of the first lunar landing. ‘A Moon For All Mankind’ is the world’s first lunar gravity simulation VR experience, created in collaboration with NASA Johnson Space Center (JSC), using the Samsung Gear VR and a custom-built rig. Having launched under embargo at the 2018 Winter Olympics and at Mobile World Congress, July sees the experience land publicly at Samsung 837, in New York City.

Read more

Jul 28, 2018

Communities Raise Their Voices on Genetic Engineering

Posted by in categories: bioengineering, genetics

From Martha’s Vineyard to New Zealand, the power of new genetic tools provokes concern and collaboration.


Crispr technology may allow scientists to change the environment forever, but working with the affected localities presents a challenge.

Read more

Jul 22, 2018

2018 Speakers

Posted by in categories: bioengineering, biotech/medical, food, genetics, robotics/AI, transhumanism

I’m excited to share I’ll be speaking/debating at the upcoming #Biohack the Planet 2018 conference in Oakland on Aug 31 & Sept 1. Many interesting biohackers will be there. Tickets are still available and very reasonably priced right now, but they will likely sell out. Hope to see you there! Here’s the speaker list: http://biohacktheplanet.com/2018-speakers/ #transhumanism #biohacker & ticket page: https://www.eventbrite.com/e/biohack-the-planet-2018-ticket


Bryan Johnson is the founder and CEO of Kernel, OS Fund and Braintree.

In 2016, Bryan invested $100M in Kernel to build advanced neural interfaces to treat disease and dysfunction, illuminate the mechanisms of intelligence, and extend cognition. Kernel is on a mission to dramatically increase our quality of life as healthy lifespans extend. He believes that the future of humanity will be defined by the combination of human and artificial intelligence (HI +AI). In 2014, Bryan invested $100M to start OS Fund which invests in entrepreneurs commercializing breakthrough discoveries in genomics, synthetic biology, artificial intelligence, precision automation, and new materials development. Bryan founded Braintree in 2007, later acquiring Venmo, which he sold to Ebay in 2013 for $800M. He is an outdoor-adventure enthusiast, pilot, and author of a children’s book, Code 7.

Continue reading “2018 Speakers” »

Jul 21, 2018

The safety of CRISPR-Cas9 gene editing is being debated

Posted by in categories: bioengineering, biotech/medical, genetics

When CRISPR-Cas9 is used to edit genomes, off-target DNA damage is more common than previously thought.


A GREAT deal rides on the accuracy of the gene-editing tool known as CRISPR-Cas9. Since its discovery in 2012 it has become popular for tinkering with genomes of all kinds, thanks to its ability to make editing cheap and easy. Firms such as CRISPR Therapeutics, Intellia Therapeutics and Editas Medicine have been built on the idea that it could be used to develop treatments for human diseases. Editas, based in Cambridge, Massachusetts, announced this year that it would work on five new human medicines over the next five years.

In China the technology is already in clinical use. In Hangzhou Cancer Hospital, for example, CRISPR-Cas9 is being employed to engineer immune-system cells removed from patients with cancer of the oesophagus. The hope is that when the engineered cells are returned to a patient’s body, the editing will have improved their ability to attack tumours. More studies involving human beings are expected in other countries for the treatment of beta-thalassaemia, a blood disorder, and Leber’s congenital amaurosis, a form of blindness. Further ahead, there is hope that CRISPR-Cas9 will help treat diseases such as AIDS, cystic fibrosis, Huntington’s chorea and Duchenne muscular dystrophy.

Continue reading “The safety of CRISPR-Cas9 gene editing is being debated” »

Jul 20, 2018

Safe solid-state lithium batteries herald ‘paradigm shift’ in energy storage

Posted by in categories: bioengineering, energy

The race to produce safe, powerful and affordable solid-state lithium batteries is accelerating and recent announcements about game-changing research using a solid non-flammable ceramic electrolyte known as garnet has some in the race calling it revolutionary.

“This is a paradigm shift in ,” said Kelsey Hatzell, assistant professor of mechanical engineering. A paper – “The Effect of Pore Connectivity on Li Dendrite Propagation Within LLZO Electrolytes Observed with Synchrotron X-ray Tomography” – describing her novel research on the failure points of a garnet was published online in March in the American Chemical Society’s Energy Letters, which was among the most read ACS Letters articles that month.

Continue reading “Safe solid-state lithium batteries herald ‘paradigm shift’ in energy storage” »

Jul 19, 2018

The public doesn’t trust GMOs. Will it trust CRISPR?

Posted by in categories: bioengineering, biotech/medical, food

There’s a huge opportunity to improve agriculture with gene editing. But we need to give CRISPR a chance.

Read more

Page 1 of 6412345678Last